<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HE8970D9EB61B4F1DB9469916833550F8" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 1563 IH: Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-02-25</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 1563</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250225">February 25, 2025</action-date><action-desc><sponsor name-id="C001130">Ms. Crockett</sponsor> (for herself and <cosponsor name-id="G000589">Mr. Gooden</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HJU00">Committee on the Judiciary</committee-name>, and in addition to the Committee on <committee-name committee-id="HIF00">Energy and Commerce</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful.</official-title></form><legis-body id="H3ED31EC72E934165BE3EE201BD7A8CB1" style="OLC"> 
<section id="HAB6E54FD911048FE8DF99386509918FC" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act</short-title></quote> or the <quote><short-title>STOP Fentanyl and Xylazine Act</short-title></quote>.</text></section> <section id="HCA8F2F015C9D4078BD96143844D44A9E" section-type="subsequent-section"><enum>2.</enum><header>Clarification regarding the treatment of equipment that indicates the presence of fentanyl or xylazine in a compound</header><text display-inline="no-display-inline">Section 422 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/863">21 U.S.C. 863</external-xref>) is amended by adding at the end the following:</text>
<quoted-block style="OLC" id="HDCE411661CE145D38CEE5BB883FDD322" display-inline="no-display-inline">
<subsection id="HF0F46D93971B48D4BB1DA864D4E0DB50"><enum>(g)</enum><header>Clarification</header><text display-inline="yes-display-inline">This section does not apply to the possession, sale, purchase, importation, exportation, or transportation of equipment for which the intended use is to indicate the presence of fentanyl or xylazine in a compound.</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></section> </legis-body></bill>

